Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 70771-1520

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 70771-1520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (B2409df0 E9ba 42fc Ba50 A45d5e7e36d6 01)

This is a description of Sevelamer Carbonate Tablets, a medication used to control phosphate levels in the blood in people with chronic kidney disease. Each tablet contains 800 mg of sevelamer carbonate, and the recommended dosage should be reviewed in the package insert. This medication should be stored between 20°C to 25°C (68°F to 77°F), in a tightly closed container and protected from moisture. It is manufactured by Cadila Healthcare Ltd. in Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.